New Multiple Sclerosis Drug, Backed by 40 Years of Research, Could Halt Disease
March 28, 2017
March 28, 2017
SAN FRANCISCO, March 28 -- The University of California's San Francisco campus issued the following news release:
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) - is holding new hope for the hundreds of thousands Americans living with the disease.
It also highlights the importance of clinician-scientists like UC San Francisco's Stephen Hauser, MD, who are working to transform research into cures for . . .
A newly approved drug that is the first to reflect the current scientific understanding of multiple sclerosis (MS) - is holding new hope for the hundreds of thousands Americans living with the disease.
It also highlights the importance of clinician-scientists like UC San Francisco's Stephen Hauser, MD, who are working to transform research into cures for . . .